Mesothelioma, Malignant: all 418 studies
Page 4 of 5. Open to participants first (73), then studies with results posted, then the rest; newest registration first within each.
- A Clinical Study With Tremelimumab as Monotherapy in Malignant MesotheliomaStatus unknownNCT01649024Phase 2
- Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural MesotheliomaCompletedNCT01644994Phase 1/2
- Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma TreatmentSuspendedNCT01627795Phase 1/2
- PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural MesotheliomaTerminatedNCT01604005Phase 3
- Do Your Genes Put You at a Higher Risk of Developing MesotheliomaCompletedNCT01590472
- Ganetespib With Platinum, in Patients With Malignant Pleural MesotheliomaCompletedNCT01590160Phase 1/2
- A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural MesotheliomaStatus unknownNCT01569919Phase 2
- Intrapleural Measles Virus Therapy in Patients With Malignant Pleural MesotheliomaCompletedNCT01503177Phase 1
- A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural MesotheliomaCompletedNCT01486368Phase 2
- SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural MesotheliomaTerminatedNCT01445392Phase 1
- Amatuximab for High Mesothelin CancersTerminatedNCT01413451Early Phase 1
- Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPMCompletedNCT01358084Phase 2
- Psychosocial Needs and Exploration of Online Support for Patients With MesotheliomaCompletedNCT01356251Not applicable
- Autologous Redirected RNA Meso-CIR T CellsCompletedNCT01355965Phase 1
- A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural MesotheliomaWithdrawnNCT01353482Phase 1/2
- Trimodality Therapy for Malignant Pleural MesotheliomaStatus unknownNCT01343264
- Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the BodyWithdrawnNCT01325753Not applicable
- Dendritic Cell Vaccination for Patients with Solid TumorsCompletedNCT01291420Phase 1/2
- Cisplatin With Alimta or Gemcitabine in Long Infusion for MesotheliomaStatus unknownNCT01281800Phase 2
- A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural MesotheliomaStatus unknownNCT01279967Phase 2
- Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural MesotheliomasTerminatedNCT01258868Phase 1
- Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma TreatmentCompletedNCT01243632Phase 2
- Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant MesotheliomaCompletedNCT01241682Phase 1
- Intrapleural Gene Transfer for Pleural MesotheliomaCompletedNCT01212367Phase 1
- Standard Chemotherapy With of Without Axitinib in Malignant MesotheliomaCompletedNCT01211275Phase 1/2
- Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural MesotheliomasTerminatedNCT01143545Phase 1
- Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT)CompletedNCT01134146Phase 1
- Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)CompletedNCT01126346Not applicable
- Combination Gene Transfer and ChemotherapyCompletedNCT01119664Phase 1
- AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaWithdrawnNCT01105390Phase 2
- A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.CompletedNCT00996567Phase 2
- Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal MesotheliomaStatus unknownNCT00996385Phase 2
- Response Evaluation in Malignant Pleural MesotheliomaStatus unknownNCT00969098
- Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial HyperplasiaStatus unknownNCT00899613
- Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107TerminatedNCT00898547
- Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT00897442
- Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or VermiculiteCompletedNCT00897247
- Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for MesotheliomaTerminatedNCT00895648Phase 2
- Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural MesotheliomaStatus unknownNCT00886028Phase 2
- Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) PatientsCompletedNCT00867711
- Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant MesotheliomaCompletedNCT00821860Phase 3
- Short Neoadjuvant Hemithoracic IMRT for MPMCompletedNCT00797719Phase 1/2
- Sorafenib in Previously Treated Malignant MesotheliomaStatus unknownNCT00794859Phase 2
- An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant MesotheliomaCompletedNCT00787410Phase 2
- CryoSpray Ablation(tm)Thoracic Patient RegistryWithdrawnNCT00785239
- Optical Coherence Tomography of the Airway for Lung Cancer or Lung DiseaseWithdrawnNCT00733252
- An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant MesotheliomaStatus unknownNCT00685204Phase 2
- A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant MesotheliomaWithdrawnNCT00668499Phase 1/2
- Dasatinib in Resectable Malignant Pleural MesotheliomaCompletedNCT00652574Phase 1
- Mesothelioma Avastin Plus Pemetrexed-cisplatin StudyCompletedNCT00651456Phase 2/3
- N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing ChemotherapyTerminatedNCT00637624Not applicable
- Phase II Study of Valproate and Doxorubicin in Malignant MesotheliomaCompletedNCT00634205Phase 2
- Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard TreatmentTerminatedNCT00585845Phase 1
- Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural MesotheliomaCompletedNCT00571298Phase 1
- A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant MesotheliomaStatus unknownNCT00551252Phase 2
- Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by SurgeryCompletedNCT00541073Phase 2
- Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural MesotheliomaCompletedNCT00535951Phase 1
- Bortezomib in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00513877Phase 2
- Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural MesotheliomaCompletedNCT00484276Phase 2
- Tomotherapy Treatment for MesotheliomaCompletedNCT00469196Phase 2
- Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant MesotheliomaCompletedNCT00458913Phase 2
- Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural MesotheliomaCompletedNCT00407459Phase 2
- Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant MesotheliomaCompletedNCT00402766Phase 1
- Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural MesotheliomaCompletedNCT00386815Phase 2
- Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest CancerCompletedNCT00372840Not applicable
- Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural MesotheliomaCompletedNCT00354393Phase 2
- Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00334594Phase 2
- A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung CancerCompletedNCT00325494Phase 1
- Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung CancerTerminatedNCT00281125Phase 1/2
- Dendritic Cell-based Immunotherapy in MesotheliomaCompletedNCT00280982Phase 1
- Study of Carboplatin and Vinorelbine in Malignant Pleural MesotheliomaCompletedNCT00272558Phase 2
- Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By SurgeryStatus unknownNCT00253409Not applicable
- Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural MesotheliomaCompletedNCT00251550Phase 1/2
- Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00227630Phase 2
- A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of MesotheliomaCompletedNCT00190762Phase 3
- Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos WorkersCompletedNCT00188890
- Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural MesotheliomaCompletedNCT00165555Phase 1
- Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium ThiosulfateCompletedNCT00165516Phase 2
- Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated MesotheliomaCompletedNCT00137826Phase 2
- Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.CompletedNCT00107432Phase 2
- Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or MediastinumTerminatedNCT00094978Phase 1
- Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00075699Phase 3
- Immunotoxin Therapy in Treating Patients With Advanced Solid TumorsCompletedNCT00066651Phase 1
- Alanosine in Treating Patients With CancerCompletedNCT00062283Phase 2
- Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal MesotheliomaCompletedNCT00061477Phase 2
- Surgery and Photodynamic Therapy in Treating Patients With Malignant MesotheliomaCompletedNCT00054002Phase 2
- PTK787/ZK 222584 in Treating Patients With Unresectable Malignant MesotheliomaCompletedNCT00053885Phase 2
- ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.Approved for marketingNCT00040625
- Erlotinib in Treating Patients With Malignant Mesothelioma of the LungCompletedNCT00039182Phase 2
- Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural MalignanciesCompletedNCT00037817Phase 1
- Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the LungCompletedNCT00030745Phase 2
- Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
- Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant MesotheliomaStatus unknownNCT00030459Phase 2
- EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural CancerTerminatedNCT00028782Not applicable
- Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant MesotheliomaCompletedNCT00027703Phase 2
- Ecteinascidin 743 in Treating Patients With Malignant MesotheliomaTerminatedNCT00027508Phase 2
- Gefitinib in Treating Patients With Malignant MesotheliomaCompletedNCT00025207Phase 2
- Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal CancerStatus unknownNCT00024271Phase 2
- Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung CancerCompletedNCT00024076Phase 2
- Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the LungsCompletedNCT00020124Phase 1